You have 9 free searches left this month | for more free features.

Prostate adenocarcinoma

Showing 1 - 25 of 8,290

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Adenocarcinoma Trial in Fuzhou (Personalized Optimization of Systematic Prostate Biopsy)

Recruiting
  • Prostate Adenocarcinoma
  • Personalized Optimization of Systematic Prostate Biopsy
  • Fuzhou, Fujian, China
    Department of Urology, Fujian Union Hospital, Fujian Medical Uni
Aug 16, 2023

Adding MR Fusion to Standard US Guided Prostate Biopsy

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • TRUS biopsy
  • Tucson, Arizona
    University of Arizona
Jan 27, 2023

Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Prostate SBRT (stereotactic body radiation therapy) with focal boost
  • Madrid, Spain
    La Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023

Prostate Adenocarcinoma Trial in Kansas City (Osanetant)

Recruiting
  • Prostate Adenocarcinoma
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Prostate Adenocarcinoma Trial in Duarte, Los Angeles, Durham (Fasting Mimicking Diet (FMD), Usual Diet)

    Not yet recruiting
    • Prostate Adenocarcinoma
    • Fasting Mimicking Diet (FMD)
    • Usual Diet
    • Duarte, California
    • +2 more
    Apr 27, 2023

    dapted Strategy Including Magnetic Resonance Imaging and

    Completed
    • Prostate Cancer
    • Prostate Adenocarcinoma
      • Ankara, Turkey
        Ankara University School of Medicine
      Sep 6, 2023

      Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)

      Not yet recruiting
      • Prostate Adenocarcinoma
      • 68-Ga PSMA11
      • Dallas, Texas
        UT Southwestern Medical Center
      Sep 12, 2023

      Prostate Adenocarcinoma Trial (De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac)

      Not yet recruiting
      • Prostate Adenocarcinoma
      • De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac
      • (no location specified)
      Jan 23, 2023

      Prostate Adenocarcinoma Trial in Kansas City (Osanetant)

      Recruiting
      • Prostate Adenocarcinoma
      • Kansas City, Kansas
        The University of Kansas Cancer Center, Westwood Campus
      Jan 3, 2023

      Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

      Recruiting
      • Prostate Adenocarcinoma
      • +7 more
      • High-Dose Rate Brachytherapy
      • Stereotactic Body Radiation Therapy
      • Los Angeles, California
        University of California at Los Angeles / Jonsson Comprehensive
      Oct 13, 2022

      Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a

      Recruiting
      • Prostate Cancer
      • +4 more
      • Performing cognitive prostate biopsy with a radiologist's guidance with map
      • Performing cognitive prostate biopsy without a radiologist's guidance with map
      • Istanbul, Turkey
        Marmara University, School of Medicine, Department of Urology
      Jun 5, 2023

      Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)

      Completed
      • Prostate Adenocarcinoma
      • F-18 fluciclovine-PET/CT scan
      • Tucson, Arizona
        University of Arizona
      Aug 12, 2022

      Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

      Recruiting
      • Castration-Resistant Prostate Carcinoma
      • Prostate Adenocarcinoma
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 23, 2022

      Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,

      Not yet recruiting
      • Prostatic Neoplasms
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

      Not yet recruiting
      • Prostate Adenocarcinoma
      • +2 more
      • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
      • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Jan 4, 2023

      Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

      Active, not recruiting
      • Castration-Resistant Prostate Carcinoma
      • +6 more
      • San Francisco, California
      • +1 more
      Sep 20, 2022

      Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)

      Not yet recruiting
      • Prostate Adenocarcinoma
      • Biopsy
      • +3 more
      • Los Angeles, California
      • +4 more
      Sep 7, 2023

      Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

      Active, not recruiting
      • Metastatic Prostate Adenocarcinoma
      • +6 more
      • Intensity-Modulated Radiation Therapy
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 5, 2023

      Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (other, radiation, procedure)

      Not yet recruiting
      • Prostate Cancer
      • +2 more
      • Risk Map Decision Support System (DSS).
      • +2 more
      • (no location specified)
      Jan 25, 2023

      Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)

      Not yet recruiting
      • Prostate Adenocarcinoma
      • Localized Prostate Carcinoma
      • High Dose Rate Monotherapy
      • San Francisco, California
        University of California, San Francisco
      Dec 27, 2022

      Prostate Cancer, Prostate Adenocarcinoma Trial in Columbia (Ga-68-PSMA-11)

      Terminated
      • Prostate Cancer
      • Prostate Adenocarcinoma
      • Columbia, Missouri
        Truman VA Hospital
      Feb 15, 2023

      Prostate Adenocarcinoma, Prostate Cancer Trial (Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused

      Not yet recruiting
      • Prostate Adenocarcinoma
      • Prostate Cancer
      • Transvesical Single Port Robotic Partial Prostatectomy
      • High-intensity focused ultrasound (HIFU)
      • (no location specified)
      Nov 3, 2022

      Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

      Active, not recruiting
      • Prostate Cancer
      • +5 more
      • 131I-PSMA-1095 Radioligand Therapy (RLT)
      • Montreal, Quebec, Canada
        Stephan Probst
      Oct 24, 2022

      Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)

      Completed
      • Prostate Disease
      • +6 more
      • Self-Administered Nitrous Oxide
      • Oxygen
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Mar 25, 2023